Prof. Dr. med. Volkmar Müller would like to invite you to Hamburg for an interactive and up-to-date event on June 22nd. The treatment of patients with breast cancer has developed dramatically in recent years. In addition to the progression of treatment in the established subgroups (hormone receptor and HER2 status), there are now therapies that are based on individual molecular characteristics, such as the PARP inhibitor therapy in BRCA mutant patients. In addition, tests are under development to establish additional markers within subgroups to predict the efficacy of therapy.We would like to introduce all these aspects to you and discuss the implementation for our patients. We will take into account the current recommendations of AGO Mamma and the latest results from ASCO. In addition, we will have enough time for case discussions in small groups and a personal exchange. We look forward to an exciting discussion with you! The Breast Cancer Breast Cancer 2019 is a brand new MCI Academy event series. From June to August 2019, 5 events will take place throughout Germany on the latest study results and therapy trends for breast cancer. In keynote speeches and ContentCamps a high practical relevance is conveyed and the discussion and active participation of the participants are promoted.The MCI Academy is the organizer of content-centered medical continuing education events that combine completely new types of event formats with innovative forms of interaction. URL: Tickets: https://go.evvnt.com/399714-2?pid=5569. Speaker: Prof. Dr. med. Volkmar Müller. Time: 9:00 am to 3:00 pm. Venue details: Radisson Blu Hotel Hamburg, Marseiller Straße 2, Hamburg, 20355, Germany.